Get the Stockscreener App
7.94
12.94%
0.91
After Hours:
7.94
89 Bio Inc stock is traded at $7.94, with a volume of 4.34M.
It is up +12.94% in the last 24 hours and down -0.50% over the past month.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
See More
Previous Close:
$7.03
Open:
$7.03
24h Volume:
4.34M
Relative Volume:
4.79
Market Cap:
$933.60M
Revenue:
-
Net Income/Loss:
$-174.61M
P/E Ratio:
-3.763
EPS:
-2.11
Net Cash Flow:
$-165.54M
1W Performance:
+3.25%
1M Performance:
-0.50%
6M Performance:
+0.13%
1Y Performance:
-22.39%
1-Day Range:
$6.60
$7.95
1-Week Range:
$6.43
$8.09
52-Week Range:
$6.43
$16.63
89 Bio Inc Stock (ETNB) Company Profile
Name
89 Bio Inc
Sector
Industry
Phone
(415) 432-9270
Address
142 SANSOME STREET, SAN FRANCISCO, CA
Compare ETNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
7.94 | 933.60M | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-22-24 | Resumed | BofA Securities | Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-10-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-28-23 | Initiated | UBS | Buy |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| May-12-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-26-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-29-21 | Resumed | BTIG Research | Buy |
| May-25-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Apr-21-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-19-20 | Initiated | Raymond James | Strong Buy |
| Sep-25-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-31-20 | Initiated | Piper Sandler | Overweight |
| Jul-23-20 | Initiated | BTIG Research | Buy |
| Jul-07-20 | Initiated | Chardan Capital Markets | Buy |
| Dec-09-19 | Initiated | BofA/Merrill | Neutral |
| Dec-09-19 | Initiated | Oppenheimer | Outperform |
| Dec-09-19 | Initiated | RBC Capital Mkts | Outperform |
| Dec-09-19 | Initiated | SVB Leerink | Outperform |
View All
89 Bio Inc Stock (ETNB) Latest News
89bio (NASDAQ:ETNB) Sets New 1-Year LowWhat's Next? - MarketBeat
89bio stock hits 52-week low at $6.96 amid market challenges - Investing.com Canada
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
89bio Grants Inducement Stock Options to New Employee Under 2023 Plan - StockTitan
89bio (NASDAQ:ETNB) Shares Down 4.5%Here's What Happened - MarketBeat
Wellington Management Group LLP Reduces Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Fmr LLC Purchases 70,129 Shares of 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
89bio stock hits 52-week low at $6.96 amid market challenges By Investing.com - Investing.com South Africa
Short Interest in 89bio, Inc. (NASDAQ:ETNB) Increases By 6.5% - MarketBeat
89Bio's SWOT analysis: pegozafermin's potential in MASH treatment stock By Investing.com - Investing.com Canada
89Bio's SWOT analysis: pegozafermin's potential in MASH treatment stock - Investing.com India
89bio issues retention RSUs to top executives By Investing.com - Investing.com South Africa
89bio issues retention RSUs to top executives - Investing.com
89bio Strengthens Leadership Retention with New RSUs - TipRanks
89bio : Management Change/Compensation Form 8 K - Marketscreener.com
89bio (NASDAQ:ETNB) Upgraded at Raymond James - Defense World
89bio (NASDAQ:ETNB) Shares Down 5%Here's What Happened - MarketBeat
89bio (NASDAQ:ETNB) Stock Rating Upgraded by Raymond James - MarketBeat
Charles Schwab Investment Management Inc. Purchases 53,932 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio CEO Rohan Palekar buys $39,450 in company stock By Investing.com - Investing.com Australia
Insider Buying: 89bio, Inc. (NASDAQ:ETNB) CEO Acquires 5,000 Shares of Stock - MarketBeat
CEO Rohan Palekar Increases Stake in 89bio Inc (ETNB) with Recen - GuruFocus.com
89bio CEO Rohan Palekar buys $39,450 in company stock - Investing.com
Analysts Set 89bio, Inc. (NASDAQ:ETNB) PT at $30.33 - Defense World
89bio, Inc. (NASDAQ:ETNB) Director Charles Mcwherter Purchases 10,000 Shares - MarketBeat
Insider Buying: Charles Mcwherter Acquires Shares of 89bio Inc (ETNB) - GuruFocus.com
89bio director Charles McWherter purchases $80,000 in stock By Investing.com - Investing.com Nigeria
89bio director Charles McWherter purchases $80,000 in stock - Investing.com
89bio, Inc. (NASDAQ:ETNB) Shares Purchased by Jacobs Levy Equity Management Inc. - MarketBeat
89bio (NASDAQ:ETNB) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Analysts Set 89bio, Inc. (NASDAQ:ETNB) Target Price at $30.33 - MarketBeat
89Bio's SWOT analysis: pegoza's potential in MASH treatment faces market hurdles - Investing.com Nigeria
Redmile Group LLC Sells 175,806 Shares of 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
Janus Henderson Group PLC Purchases 1,882,108 Shares of 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
Canterra Minerals announces private placement for proceeds of up to C$3M - MSN
Why Is 89bio, Inc. (ETNB) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Insider Monkey
ICICI Bank Ltd. ADR (NYSE: IBN) Up 27.89% This Year: What Is Going To Happen Next - Stocks Register
10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds - Insider Monkey
eHealth initiated with a Neutral at UBS - MSN
HighVista Strategies LLC Acquires New Shares in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
LMS Compliance Boosts ESG Standards for Malaysian SMEs - MSN
89bio, Inc. (NASDAQ:ETNB) Shares Purchased by Walleye Capital LLC - MarketBeat
Erste Asset Management GmbH Acquires New Position in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
Stock market today: Senti Biosciences +412.04%, NovoCure +31.89% among top gainers in early trading - Business Upturn
BPGbio reports data on brain-penetrant microtubule destabilizing agent BRG-399 - BioWorld Online
PDT Partners LLC Buys New Shares in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
89bio Grants Stock Options to New Employees in Key Retention Move | ETNB Stock News - StockTitan
89 Bio Inc Stock (ETNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
89 Bio Inc Stock (ETNB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McWherter Charles | Director |
Dec 05 '24 |
Buy |
8.00 |
10,000 |
80,000 |
10,000 |
| PALEKAR ROHAN | Chief Executive Officer |
Nov 22 '24 |
Buy |
8.35 |
10,000 |
83,500 |
466,236 |
| Le-Nguyen Quoc | See Remarks |
Oct 30 '24 |
Sale |
8.12 |
27,955 |
226,995 |
187,796 |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):